Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome
Nutrients · 2024
DOI: 10.3390/nu16121967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Sylvia Cruchet Muñoz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nutrición y Tecnología de los Alimentos "Dr. Fernando Monckeberg", Área Nutrición Humana, Universidad de Chile, El Líbano 5524, Macul, S…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Probiotics, Bifidobacterium longum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novozymes (Denmark), Biocodex (France), PrecisionBiotics Group Ltd..
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) and vitamin D deficiency are common among children in Latin America. Previous studies show that Bifidobacterium longum35624TM improves IBS symptoms in adults. This real-world, single-arm, open-label study conducted in Chile investigated the effects of B. longum 35624 (1 × 109 colony-forming units, 12 weeks) on gastrointestinal symptoms (adapted IBS severity scoring system [IBS-SSS]; adapted Questionnaire on Pediatric Gastrointestinal Symptoms [QPGS], and Bristol Stool Form Scale) in 64 children and adolescents (8–18 years) and explored the relationship with baseline vitamin D status. Improvements in all IBS-SSS domains and composite score were observed at week 6 and 12 (p < 0.0007 versus baseline), with 98.3% of participants experiencing numerical improvements in ≥3 domains. Clinically meaningful improvement was seen in 96.6% of participants. The distribution of IBS-SSS severity categories shifted from moderate/severe at baseline to mild/remission (p < 0.0001). Improvements were not maintained during the two-week washout. Low baseline serum vitamin D levels did not correlate to IBS severity or probiotic response. QPGS significantly decreased from baseline to week 6 (p = 0.0005) and 12 (p = 0.02). B. longum 35624 may improve IBS symptoms in children and adolescents, even those with vitamin D deficiency. A confirmatory randomized controlled trial and further exploration of probiotic response and vitamin D status are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Nutrición y Tecnología de los Alimentos "Dr. Fernando Monckeberg", Área Nutrición Humana, Universidad de Chile, El Líbano 5524, Macul, Santiago 7830490, Chile.
- Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Campus Santiago, Chile. Av. Ejército 146, Santiago 8370003, Chile.
- Faculty of Graduate Business and Education Programs, Keiser University eCampus, 1900 West Commercial Boulevard. Ste 100, Ft. Lauderdale, FL 33309, USA.
- Facultad de Medicina, Universidad de los Andes, Monseñor Álvaro del Portillo 12455, Las Condes, Santiago 7620001, Chile.
- Hospital Militar de Santiago, Av. Fernando Castillo Velasco 9100, La Reina, Santiago 7880047, Chile.
- Clínica Red Salud Vitacura de Santiago, Tabancura 1141, Vitacura, Santiago 7650018, Chile.
ORCID-Profile: Sandra Verbeke Palma
Förderung
- Novozymes (Denmark)
- Biocodex (France)
- PrecisionBiotics Group Ltd.
- Axon Pharma
Zitieren
APA
Cruchet Muñoz, S., Verbeke Palma, S., Lera Marqués, L., Espinosa Pizarro, M. N., Malig Mechasqui, J., & Sorensen, K. (2024). Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome. Nutrients. https://doi.org/10.3390/nu16121967
Vancouver
Cruchet Muñoz S, Verbeke Palma S, Lera Marqués L, Espinosa Pizarro MN, Malig Mechasqui J, Sorensen K. Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome. Nutrients. 2024. doi:10.3390/nu16121967
BibTeX
@article{CruchetMuoz2024,
author = {Cruchet Muñoz, Sylvia and Verbeke Palma, Sandra and Lera Marqués, Lydia and Espinosa Pizarro, María Nelly and Malig Mechasqui, Jacqueline and Sorensen, Katy},
title = {Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16121967}
}
EUVIMED